<DOC>
	<DOCNO>NCT00918814</DOCNO>
	<brief_summary>Dose Ranging Dose Frequency LIPO-102</brief_summary>
	<brief_title>Dose Ranging Dose Frequency LIPO-102</brief_title>
	<detailed_description />
	<criteria>Male non pregnant female Good general health Sufficient abdominal fat injection Signed informed consent Known hypersensitivity study drug Treatment investigational agent within 30 day first dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>